Propranolol as the first-line therapy for infantile hemangiomas: Preliminary results of two centers

Journal of Drugs in Dermatology

Volumn 11, Issue 7, 2012, Pages 808-811

  Celik, Ahmet ^a   Tiryaki, Sibel ^a   Musayev, Allahverdi ^b   Kismali, Erkan ^a   Levent, Erturk ^a   Ergun, Orkan ^a  

^a EGE UNIVERSITY   (Turkey)

^b Baku Research Institute on Pediatrics   (Azerbaijan)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL;

ARTICLE; CAPILLARY HEMANGIOMA; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIMARY HEALTH CARE; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMANGIOMA; HUMANS; INFANT; MALE; PROPRANOLOL; TREATMENT OUTCOME;

EID: 84866171968     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Frieden IJ, Haggstrom AN, Drolet BA: Infantile hemangiomas: Current Knowledge, Future Directions. Proocedings of a Research Workshop on Infantile hemanjiomas. Pediatr Dermatol. 1994;22:383-406.
2. Takahashi K, Mulliken JB, Kozakewich HP, et al: Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994;93:2357-2364.
3. Léauté-Labrèze C, Roque ED, Hubiche T: Propranolol for severe hemangiomas of infancy. New Engl J Med. 2008;358:2649-2651.
4. Tsang MW, Stud M, Garzon M, et al: How to measure a growing hemangioma and assess response to therapy. Pediatr Dermatol. 2006;23:187-190.
5. Waner M, Suen JY: Treatment of hemangiomas of the head and neck. Laryngoscope. 1992;102:1123-1132.
6. Starkey E, Shahidullah H: Propranolol for infantile haemangiomas: a review. Arch Dis Child. 2011;96:890-893.
7. Lawley LP, Siegfried E, Todd JL: Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations. Pediatr Dermatol. 2009,26:610-614.
8. Arneja JS, Pappas PN, Shwayder TA, et al: Management of Complicated Facial Hemangiomas with β-Blocker (Propranolol) Therapy. Plast Reconstr Surg. 2011,127:1742-1743.
9. Schiestl C, Neuhaus K, Zoller S, et al: Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr 2011;170:493-501.
10. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action. Br J Dermatol. 2010;163:269-274.
11. Zvulunov A, McCuaig C, Frieden IJ. Oral Propranolol Therapy for Infantile Hemangiomas Beyond the Proliferation Phase: A Multicenter Retrospective Study. Pediatr Dermatol. 2011;28:294-298.